Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma
Clinical trial NCT03143036 · UNKNOWN
Trial details
- NCT number
- NCT03143036
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2019-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.